JAGSNPHARM
Invest with MTF
Invest Now
Invest in Jagsonpal Pharmaceuticals with 2.2X leverage
Performance
- Low
- ₹173
- High
- ₹178
- 52 Week Low
- ₹155
- 52 Week High
- ₹302
- Open Price₹177
- Previous Close₹179
- Volume18,303
- 50 DMA₹184.66
- 100 DMA₹197.72
- 200 DMA₹208.16
Investment Returns
- Over 1 Month -2.43%
- Over 3 Month -18.41%
- Over 6 Month -29.54%
- Over 1 Year -27.75%
Smart Investing Starts Here Start SIP with Jagsonpal Pharmaceuticals for Steady Growth!
Jagsonpal Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.5
- PEG Ratio
- -1.3
- Market Cap Cr
- 1,168
- P/B Ratio
- 4.6
- Average True Range
- 7.35
- EPS
- 6.37
- Dividend Yield
- 1.4
- MACD Signal
- -3.72
- RSI
- 46.89
- MFI
- 45.43
Jagsonpal Pharmaceuticals Financials
Jagsonpal Pharmaceuticals Technicals
EMA & SMA
Current Price
₹174.56
-4.3
(-2.4%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹175.93
- 50 Day
- ₹184.66
- 100 Day
- ₹197.72
- 200 Day
- ₹208.16
Resistance and Support
175.19
- R3 182.36
- R2 180.18
- R1 177.37
- S1 172.38
- S2 170.20
- S3 167.39
Jagsonpal Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Jagsonpal Pharmaceuticals F&O
About Jagsonpal Pharmaceuticals
- NSE Symbol
- JAGSNPHARM
- BSE Symbol
- 507789
- Managing Director
- Mr. Manish Gupta
- ISIN
- INE048B01035
Similar Stocks to Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals FAQs
Jagsonpal Pharmaceuticals share price is ₹174 As on 13 February, 2026 | 23:11
The Market Cap of Jagsonpal Pharmaceuticals is ₹1167.6 Cr As on 13 February, 2026 | 23:11
The P/E ratio of Jagsonpal Pharmaceuticals is 28.5 As on 13 February, 2026 | 23:11
The PB ratio of Jagsonpal Pharmaceuticals is 4.6 As on 13 February, 2026 | 23:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.